Take Your Trading To The Next Level. Get Started Here!

Novo Nordisk’s Wegovy wins FDA approval for cutting heart disease risks, in move that could expand insurance coverage

March 8, 2024 Comments Off

That decision could widen insurance coverage for the drug and similar treatments for obesity, which has been a major barrier to access for patients.